ATLASProQR Therapeutics N.V. (PRQR) earnings date: Nov 5, 2026
ProQR Therapeutics N.V. (PRQR) reports earnings for the quarter ended Sep 30, 2026 on Thu, Nov 5, 2026, before the open. Analysts expect EPS of -$0.11.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on PRQR
| Last price | $1.39 (-3.5%) |
|---|---|
| Normal 1-day range (±1σ) | ±4.0% |
| Earnings beat history | Beat the EPS estimate in 5 of the last 5 reports |
These figures come from the same calibrated model and valuation as the ProQR Therapeutics N.V. stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
ProQR Therapeutics N.V. reports on Nov 5, 2026. One email the day before, with ATLAS’s read on ProQR Therapeutics N.V.. You can switch it off at any time.
Alert me before PRQR reportsFree to start. Creating an account takes under a minute.
PRQR earnings at a glance
| Next report (confirmed) | Thu, Nov 5, 2026 |
|---|---|
| Time | Before the open |
| Period | Quarter ended Sep 30, 2026 |
| EPS estimate | -$0.11 |
| Last report | Aug 13, 2026 · Beat |
| Beat rate (last 5 reports) | 5 of 5 (100%) |
| Average EPS surprise | +31.6% |
| Average move around a report | ±4.6% (last 5) |
| Sector | Healthcare · Biotechnology |
ProQR Therapeutics N.V. earnings history: last 5 reports
ProQR Therapeutics N.V. last reported on Aug 13, 2026: EPS of -$0.09 against an estimate of -$0.18 (+50.0% surprise), a beat.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Aug 13, 2026 | -$0.18 | -$0.09 | +50.0% | Beat | +3.2% |
| May 12, 2026 | -$0.18 | -$0.15 | +16.7% | Beat | +5.6% |
| Mar 12, 2026 | -$0.12 | -$0.09 | +25.0% | Beat | +0.6% |
| Nov 6, 2025 | -$0.17 | -$0.12 | +29.4% | Beat | -6.7% |
| Oct 23, 2025 | -$0.30 | -$0.19 | +36.7% | Beat | +7.0% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for PRQR
See the fair value, the probability range and the earnings history of ProQR Therapeutics N.V. on its ATLAS page.
ProQR Therapeutics N.V. (PRQR) stock analysisPlans from €3.99 a month.
ProQR Therapeutics N.V. earnings: frequently asked questions
When does ProQR Therapeutics N.V. (PRQR) report earnings?
ProQR Therapeutics N.V. is scheduled to report on Thursday, November 5, 2026, before the open. ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
What is the EPS estimate for PRQR?
The consensus EPS estimate for the quarter ended Sep 30, 2026 is -$0.11 per share (USD). Estimates can change before the report.
How often does PRQR beat earnings estimates?
Of its last 5 reports with a recorded result, ProQR Therapeutics N.V. beat the EPS estimate 5 times; the average surprise was +31.6%. Past results do not predict the next one.
How much does PRQR move around earnings?
Over its last 5 reports the stock moved an average of 4.6% (absolute, from the close before the report day to the close after it), and finished higher 4 of 5 times.
Did ProQR Therapeutics N.V. beat earnings estimates last quarter?
ProQR Therapeutics N.V. last reported on Aug 13, 2026: EPS of -$0.09 against an estimate of -$0.18 (+50.0% surprise), a beat.
How much does PRQR usually move in a day?
On a normal trading day the ATLAS model puts PRQR’s one-day range at about ±4.0%, with a 49% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Thu, Nov 5, 2026
Educational information, not investment advice. Disclaimer